Moneycontrol
HomeNewsEconomyPolicyRBI Policy | MPC keeps repo rate unchanged at 4%, retains accommodative stance

RBI Policy | MPC keeps repo rate unchanged at 4%, retains accommodative stance

The Monetary Policy Committee has so far remained on a growth-supportive stance to guard the economy from the ill-effects of the COVID-19 pandemic.

April 08, 2022 / 11:04 IST
Story continues below Advertisement
RBI Governor Shaktikanta Das: Fighting inflation

The Monetary Policy Committee (MPC) of the Reserve Bank of India retained the key policy rate, repo, at 4 percent on April 8.

Repo is the rate at which the central bank lends short-term funds to banks. The MPC also retained the policy stance as ‘accommodative’ indicating that the rate-setting body is focused on boosting the economic growth.

Story continues below Advertisement

The reverse repo, or the rate at which the central bank borrows short-term funds from banks, has been kept unchanged at 3.35 percent.

The RBI has cut the repo rate by 250 basis points since February 2019 to help revive the growth momentum. One basis point is one hundredth of a percentage point. An accommodative stance indicates that the MPC is in readiness to cut rates or keep the rates on hold till the time the growth signals are recovering.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show